Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3706 AL 3720

Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers

Ramos de Matos M, Ferreira C, Herukka SK, Soininen H, Janeiro A, Santana I, Baldeiras I, Almeida MR, Lleó A, Dols-Icardo O, Alcolea D, Benussi L, Binetti G, Paterlini A, Ghidoni R, Nacmias B, Meulenbroek O, van Waalwijk van Doorn LJC, Kuiperi HBJ, Hausner L, Waldemar G, Simonsen AH, Tsolaki M, Gkatzima O, Resende de Oliveira C, Verbeek MM, Clarimon J, Hiltunen M, de Mendonça A, Martins M.

J Alzheimers Dis. 2018;66(2):639-652. doi: 10.3233/JAD-180512.

[The addition of memantine to galantamine increases treatment efficacy in patients with moderate dementia with Lewy bodies]

Vasenina EE, Gankina OA, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(6. Vyp. 2):32-36. doi: 10.17116/jnevro201811806232.

Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications

Tumminia A, Vinciguerra F, Parisi M, Frittitta L.

Int J Mol Sci. 2018 Oct 24;19(11):3306. doi: 10.3390/ijms19113306.

Possible Clues for Brain Energy Translation via Endolysosomal Trafficking of APP-CTFs in Alzheimer's Disease

Sivanesan S, Mundugaru R, Rajadas J.

Oxid Med Cell Longev. 2018 Oct 21;2018:2764831. doi: 10.1155/2018/2764831. eCollection 2018.

APP signaling in Alzheimer's disease

Bignante EA, Lorenzo A.

Aging (Albany NY). 2018 Nov 13;10(11):3063-3064. doi: 10.18632/aging.101641.

Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies

Chen Y, Fu AKY, Ip NY.

Pharmacol Ther. 2019 Mar;195:186-198. doi: 10.1016/j.pharmthera.2018.11.006. Epub 2018 Nov 12.

p66Shc activation promotes increased oxidative phosphorylation and renders CNS cells more vulnerable to amyloid beta toxicity

Lone A, Harris RA, Singh O, Betts DH, Cumming RC.

Sci Rep. 2018 Nov 20;8(1):17081. doi: 10.1038/s41598-018-35114-y.

Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology

Pchitskaya EI, Zhemkov VA, Bezprozvanny IB.

Biochemistry (Mosc). 2018 Sep;83(9):1068-1074. doi: 10.1134/S0006297918090080.

Current state of Alzheimer's fluid biomarkers

Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A, O'Bryant S, Scheltens P, Sevigny J, Shaw LM, Soares HD, Tong G, Trojanowski JQ, Zetterberg H, Blennow K.

Acta Neuropathol. 2018 Dec;136(6):821-853. doi: 10.1007/s00401-018-1932-x. Epub 2018 Nov 28.

Establishment of TUSMi007-A, an induced pluripotent stem cell (iPSC) line from an 83-year old Chinese Han patient with Alzheimer's disease (AD)

Wang Y, Zhang J, Lei Y, Zhao J.

Stem Cell Res. 2018 Dec;33:265-268. doi: 10.1016/j.scr.2018.11.008. Epub 2018 Nov 28.

Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease

Thawkar BS, Kaur G.

J Neuroimmunol. 2019 Jan 15;326:62-74. doi: 10.1016/j.jneuroim.2018.11.010. Epub 2018 Nov 20.

A vaccine against Alzheimer`s disease: anything left but faith?

Bachmann MF, Jennings GT, Vogel M.

Expert Opin Biol Ther. 2019 Jan;19(1):73-78. doi: 10.1080/14712598.2019.1554646. Epub 2018 Dec 17.

Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease

Rad SK, Arya A, Karimian H, Madhavan P, Rizwan F, Koshy S, Prabhu G.

Drug Des Devel Ther. 2018 Nov 22;12:3999-4021. doi: 10.2147/DDDT.S173970. eCollection 2018.

CD33 in Alzheimer's Disease - Biology, Pathogenesis, and Therapeutics: A Mini-Review

Zhao L.

Gerontology. 2019;65(4):323-331. doi: 10.1159/000492596. Epub 2018 Dec 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias